ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,585Medicare Part D Prescriptions Filled, Including Refills

Rank: 187 out of 944

$489K Total Retail Price of All Prescriptions

Rank: 223 out of 944

384 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 384 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 384 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,125 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 445 384 1 1
LEVOTHYROXINE SODIUM 380 325 2 2
LISINOPRIL 372 326 3 3
METOPROLOL SUCCINATE 361 323 4 14
INDAPAMIDE 302 259 5 130
FUROSEMIDE 268 209 6 6
AMLODIPINE BESYLATE 266 243 7 5
LOSARTAN POTASSIUM 242 200 8 16
WARFARIN SODIUM 231 206 9 7
OMEPRAZOLE 229 201 10 4
ATENOLOL 228 182 11 11
METOPROLOL TARTRATE 221 198 12 8
ATORVASTATIN CALCIUM 219 183 13 13
PRAVASTATIN SODIUM 172 153 14 17
LOVASTATIN 161 157 15 26
ALLOPURINOL 148 123 16 22
ZETIA 135 131 17 59
METFORMIN HCL 134 109 18 12
CITALOPRAM HBR 110 83 19 19
QUINAPRIL HCL 108 107 20 131
GLYBURIDE 107 94 R 21 63
CLOPIDOGREL 105 98 22 36
LANTUS SOLOSTAR 95 85 23 61
CARVEDILOL 95 81 23 30
GABAPENTIN 94 65 25 18
ISOSORBIDE MONONITRATE ER 91 87 26 52
CRESTOR 88 88 27 28
SPIRONOLACTONE 88 67 27 44
DONEPEZIL HCL 86 86 29 24
NAMENDA 85 85 30 37
FENOFIBRATE 78 40 31 58
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 67 32 29
NIFEDIPINE ER 70 45 33 148
TERAZOSIN HCL 67 63 34 99
LANTUS 66 49 35 46
TRAMADOL HCL 64 48 36 21
PLAVIX 64 59 36 55
GLIPIZIDE ER 62 23 38 89
CLONIDINE HCL 60 54 39 67
ALENDRONATE SODIUM 60 59 39 20
MIRTAZAPINE 59 59 41 35
PANTOPRAZOLE SODIUM 59 45 41 34
DIGOXIN 57 57 43 39
LOSARTAN-HYDROCHLOROTHIAZIDE 56 43 44 54
POLYETHYLENE GLYCOL 3350 55 46 45 41
TAMSULOSIN HCL 54 40 46 27
ADVAIR DISKUS 54 34 46 31
METFORMIN HCL ER 53 40 48 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.